Preclinical Evaluation of Cudetaxestat for Potential Drug-Drug Interactions

被引:0
|
作者
Yu, W. [1 ]
Rajagopalan, R. [1 ]
Lin, J. [1 ]
Ibrahim, P. [1 ]
机构
[1] Blade Therapeut Inc, San Francisco, CA USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A2719
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Potential drug-drug interactions in deceased inpatients
    Jose Pardo-Cabello, Alfredo
    Manzano-Gamero, Victoria
    Del Pozo, Esperanza
    Gomez Jimenez, Francisco Javier
    de Dios Luna, Juan
    Puche Canas, Emilio
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (02) : 325 - 328
  • [22] Prevalence and predictors of potential drug-drug interactions
    Nikolic, Bozana
    Jankovic, Slobodan
    Stojanov, Oliver
    Popovic, Jovan
    [J]. CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2014, 9 (02): : 348 - 356
  • [23] Indolealkylamines: Biotransformations and potential drug-drug interactions
    Yu, Ai-Ming
    [J]. AAPS JOURNAL, 2008, 10 (02): : 242 - 253
  • [24] Potential drug-drug interactions in the outpatient setting
    Lafata, JE
    Schultz, L
    Simpkins, J
    Chan, KA
    Horn, JR
    Kaatz, S
    Long, C
    Platt, R
    Raebel, MA
    Smith, DH
    Xi, HG
    Yood, MU
    [J]. MEDICAL CARE, 2006, 44 (06) : 534 - 541
  • [25] Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions
    Yu, DT
    Peterson, JF
    Seger, DL
    Gerth, WC
    Bates, DW
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2005, 14 (11) : 755 - 767
  • [26] EVALUATION OF DRUG-DRUG INTERACTIONS TO INFORM DRUG USE
    Zhang, Lei
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S4 - S4
  • [27] Preclinical and Healthy Volunteer Studies of Potential Drug-Drug Interactions Between Tenapanor and Phosphate Binders
    Johansson, Susanne
    Leonsson-Zachrisson, Maria
    Knutsson, Mikael
    Spencer, Andrew G.
    Labonte, Eric D.
    Deshpande, Desiree
    Kohler, Jill
    Kozuka, Kenji
    Charmot, Dominique
    Rosenbaum, David P.
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (05): : 448 - 456
  • [28] Evaluation of Potential Drug-Drug Interactions with Antidepressants in Two Tertiary Care Hospitals
    Rafi, Muhammad Salman
    Nagvi, Syed Bagir Shyum
    Khan, Muhammad Umair
    Fayyaz, Muhammad
    Ashraf, Nida
    Khan, Maosood Ahmed
    Ahmad, Akram
    Dhingra, Sameer
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2015, 9 (07) : FC05 - FC08
  • [29] Pharmacoepidemiologic and in vitro evaluation of potential drug-drug interactions of sulfonylureas with fibrates and statins
    Schelleman, H.
    Han, X.
    Brensinger, C. M.
    Quinney, S. K.
    Bilker, W. B.
    Flockhart, D. A.
    Li, L.
    Hennessy, Sean
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (03) : 639 - 648
  • [30] Evaluation of Potential Drug-Drug Interactions in Hypercholesterolemia Patients at Teaching Hospital Surabaya
    Faizah, Ana Khusnul
    Nurrahman, Nani Wijayanti Dyah
    [J]. PROCEEDINGS OF THE 4TH INTERNATIONAL CONFERENCE ON SUSTAINABLE INNOVATION 2020 - HEALTH SCIENCE AND NURSING (ICOSIHSN 2020), 2021, 33 : 302 - 304